A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome

NCT00918411 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: Ramosetron
DRUG: Placebo

Sponsor

Astellas Pharma Inc